Effect of Labetalol, Atenolol, and Nifedipine on Maternal Hemodynamics Measured by ICG in Early Pregnancy

Recruiting now

Conditions studied: Systolic Hypertension, Pregnancy Related, Diastolic Hypertension, Cardiac Output, Low, Cardiac Output, High

In brief

The purpose of the research is to characterize the effect of labetalol, atenolol, and nifedipine on maternal hemodynamics early in pregnancy. Patients will be given medication based on their hemodynamics and asked to return for a repeat measurement.

Key facts

Study ID

NCT04755764

Run by

Marshall University

People needed

60

Starts

2021-03-03

Expected to finish

2025-12-01

Last updated by the study team

2025-05-13

Who can join

Age: 18 and older, up to 45. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Patients presenting to Maternal Hypertension Center at Cabell Huntington Hospital
• English speaking
• 18-45 years old.
• Willing to provide informed consent
• Gestational age prior to 15 weeks gestation

You may not qualify if…

• Non-English speaking patients, patients
• <18 years old or >45 years old
• Not willing or able to provide consent
• Gestational age >15 weeks

Where it is running

• Maternal Hypertension Center at Cabell Huntington Hospital — Huntington, West Virginia, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.